ABC7 talked to a widow who says the drug helped her have more time with her husband.
ABC7 talked to a widow who says the drug helped her have more time with her husband.
A drug trial at Northwestern Medicine offers hopeful results to those with pancreatic cancer. GI Oncologist Dr. Deva Mahalingam is the lead author for research published on Tuesday. He reports that the drug Elraglusib was created at Northwestern, and when patients received the drug with chemotherapy, they lived longer.
'This drug was a positive trial in a very difficult to treat cancer,' Mahalingam said. Mahalingam explained that cancer in the pancreas is usually only discovered when it is advanced to stage 4. He says Elraglusib seems to allow chemo drugs to be more effective. And those who had the drug lived beyond the original diagnosis for stage 4 pancreatic cancer, which, he says, is often only six to eight months to live.
'It's slowing the growth of these cancers. It's still not a cure, but it's allowing patients to live longer compared to just being on the chemotherapy alone,' Mahalingam said.
Donna Husar was married to her husband, Matthew, 32 years. She remembers those difficult times of getting the diagnosis, prognosis, and then, the possibilities of the trial. She says he lived for two years after he started the trial. 'I'm so grateful that we did, but it was really scary not knowing, but it gave us hope, and that was all we could ask for,' Husar said. 'We tried to do the most we could with the time he had, and how he was feeling, there were days he wasn't feeling so well. But overall, he was pretty good.'
Mahalingam says he is eager to do confirmation trials and hopes those with pancreatic cancer could have access to the drug in two years. 'Hopefully, in the next few years, we can show survival is improving, give patients more time with their family,' Mahalingam said.
Northwestern University Northwestern Medicine Pancreatic Cancer Cancer Treatment Cancer Drug Pancreatic Cancer Treatment New Pancreatic Cancer Drug Pancreatic Cancer Drug Pancreas Cancer Deva Mahalingam Oncology Oncologist 18886516
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Transfer Guard Jake Fiegen Narrows Choices, Northwestern Wildcats in the MixCornell transfer Jake Fiegen, a prolific scorer and sharpshooter, has narrowed his college choices, with the Northwestern Wildcats among the finalists. The Wildcats are in need of a rebuild and Fiegen's scoring ability could prove beneficial to the program.
Read more »
Northwestern's Madison Taylor aims to lead lacrosse team back to the topThe Wildcats are led by another record-setting superstar, hoping to lead them back to the top.
Read more »
Cultivated Flowers Can Support Pollinators, Northwestern Study ShowsA new study from Northwestern University reveals that gardeners can support pollinators by including cultivated flowers in their landscapes, challenging the traditional focus on native plants alone. The research suggests a balanced approach, incorporating both cultivated and native species for maximum pollinator attraction and aesthetic appeal. The findings offer practical advice for gardeners looking to create beautiful and ecologically beneficial spaces.
Read more »
Northwestern Medicine provides guidance for improving Black maternal healthNorthwestern Medicine provides guidance for improving Black maternal health
Read more »
Reclaiming Bengali New Year in New YorkMore than a decade after leaving Bangladesh, writer Anikah Shaokat recreates her beloved Noboborsho feast in her Brooklyn home.
Read more »
Amid volunteer firefighter shortage, N.Y. rolling out a new push to bring in new recruitsFire departments across New York are opening their doors this weekend in a bid to attract sorely needed new volunteers.
Read more »